← Back

Future Planet Capital | British Co-Investment Fund

vc$570MCo-invests

Fund Size

$570M

Check Size

$0.5M$3.0M

Location

United Kingdom

Portfolio

160 companies

Activity

Statusactively investing

Links

Share this fund

Investment Thesis

Provides UK schemes with access to VC and high-growth venture opportunities, supporting the ambitions of the Mansion House Accord.

About Future Planet Capital

**Future Planet Capital** is a London-based **impact-led venture capital firm** founded in 2015 that specializes in backing high-growth companies emerging from the world's top universities and research ecosystems.[1][6] The firm manages over $460M in assets and has deployed an additional $200M through co-investment initiatives, with a portfolio of approximately 160 companies across multiple geographies and stages.[1][3] Future Planet Capital's investment strategy focuses on companies addressing UN Sustainable Development Goals, including climate change, education, health, security, and sustainable growth, with a track record of 60+ profitable exits and participation as a founding investor in eight unicorns.[1][4] The firm combines deep investment expertise with strong academic connections, employing a proprietary data-driven algorithm that tracks over 500,000 inputs to source and benchmark opportunities.[4] Future Planet Capital invests across pre-seed, seed, Series A, and growth equity stages, with typical check sizes ranging from $25,000 to $3 million, and operates with a global reach spanning Asia, Europe, the United Kingdom, and the United States.[3][5] Notable portfolio companies include **Barinthus Biotherapeutics** (formerly Vaccitech), an Oxford University spinout that listed on NASDAQ in 2021 and developed the Oxford-AstraZeneca COVID-19 vaccine.[1][4] The firm manages multiple funds and mandates on behalf of public and private investors, including sovereign wealth funds, pension funds, and local government pension funds, and maintains a long track record managing deep tech funds for the UK government and the British Business Bank.[1]

Sectors

BiotechQuantum ComputingSemiconductorsClimate TechEdtechCybersecurity

Stages

pre-seedseedseries-agrowth

Geography Focus

United Kingdom

Team

NameTitleRoleLinks
Alex LeighManaging Director, Nationalin
Alex ShadboltInvestment Manager & Impact Leadin
Andy BardPortfolio Manager
Daniel GaizeInvestment Associatein
David KnoxDirectorin
Douglas Hansen-LukeExecutive Chairmanin
Dr Andrew MuirInvestment Directorin𝕏
Ed PhillipsManaging Director, Globalin
Hassan MahmudulInvestment Managerin𝕏
Huw SparksInvestment Manager
Jessica Hilldirector - investor relations & strategic partnershipsin
Jordan OngInvestment Associatein
Luize SilinaInvestment Analystin
Lyle PentithPortfolio Managerin
Mark WhiteInvestment Director
Oliver SextonInvestment Directorin
Rupert LyleInvestment Directorin𝕏
Sakura HollowayInvestment Directorin
Sam MartinPortfolio Directorin
Shruti IyengarInvestment Directorin
Surjit KoonerManaging Director, Regionalin
Tony StottInvestment Directorin

Notable Investments

Barinthus Biotherapeutics (Vaccitech)Vaccitech23andMeRem3dy HealthStrolllNutri-San

Traits

Leads rounds

Co-invests

FAQ

What does British Co-Investment Fund invest in?

British Co-Investment Fund invests in Biotech, Quantum Computing, Semiconductors, Climate Tech, Edtech and Cybersecurity at the pre-seed, seed, series-a and growth stages.

Which geographies does British Co-Investment Fund focus on?

British Co-Investment Fund focuses on United Kingdom, and is headquartered in United Kingdom.

What is British Co-Investment Fund's typical check size?

British Co-Investment Fund typically writes checks of $0.5M to $3M.